1don MSN
Claude can now create Excel files and PowerPoints for you — here's how to use this new feature
Once enabled, Claude gains access to a private computer environment where it can write code and run programs to create the files you need. This represents a significant expansion ...
2don MSN
Microsoft makes it easier to work with Excel and Docs thanks to new AI-powered mode, how it works
We are barely three months away from 2026 and in today's scenario AI tools are being used more than ever by working professionals. For most people, their day begins with ChatGPT. Be it for planning ...
Available for Microsoft 365 Copilot users, the new agents will help you create, edit, and analyze your documents, spreadsheets, and presentations.
Microsoft added some very useful features to Excel in September 2025, but many of them are exclusive to customers belonging ...
Is Microsoft Excel’s new Copilot feature the productivity breakthrough we’ve been waiting for, or just another overhyped tool with hidden strings attached? With promises of automating tedious text ...
Japan's top power producer, JERA, will explore liquefied natural gas offtake from the Alaska LNG project, JERA and developer Glenfarne said, as talks to ink firm binding sale contracts for the ...
By Rishav Chatterjee and Katya Golubkova (Reuters) - Japan’s top power producer, JERA, will explore liquefied natural gas offtake from the Alaska LNG project, JERA and developer Glenfarne said, as ...
Sept 9 (Reuters) - U.S. liquefied natural gas producer NextDecade (NEXT.O), opens new tab said on Tuesday it has reached a positive final investment decision for the fourth liquefaction plant, known ...
Explore emerging attack methods, evolving AI-driven threats, supply chain risks, and strategies to strengthen defenses and ...
BAMAKO - Kodal Minerals PLC (AIM:KOD) has received an export permit for spodumene concentrate from its Bougouni Lithium Project in southern Mali, the company announced Thursday in a press release. The ...
Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results